bf/NASDAQ:HZNP_icon.png

NASDAQ:HZNP

Horizon Therapeutics plc

  • Stock

USD

Last Close

116.30

18/07 20:00

Volume Today

23.92M

Avg: 1.69M

PE Ratio

60.74

PFCF: 29.39

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
revenue
74.02M
-
296.95M
301.20%
757.04M
154.94%
981.12M
29.60%
1.06B
7.66%
1.21B
14.33%
1.30B
7.66%
2.20B
69.26%
3.23B
46.63%
3.63B
12.48%
cost of revenue
14.63M
-
78.75M
438.48%
219.50M
178.72%
393.27M
79.17%
546.27M
38.91%
422.32M
22.69%
362.18M
14.24%
532.70M
47.08%
794.51M
49.15%
920.20M
15.82%
gross profit
59.39M
-
218.20M
267.40%
537.54M
146.35%
587.85M
9.36%
509.96M
13.25%
785.25M
53.98%
937.85M
19.43%
1.67B
77.82%
2.43B
45.82%
2.71B
11.39%
selling and marketing expenses
68.59M
-
120.28M
75.34%
220.44M
83.28%
320.37M
45.33%
general and administrative expenses
23.57M
-
88.96M
277.48%
219.86M
147.15%
287.94M
30.97%
1.54B
-
selling general and administrative expenses
92.16M
-
209.23M
127.03%
440.31M
110.44%
608.31M
38.16%
677.36M
11.35%
692.49M
2.23%
697.11M
0.67%
973.23M
39.61%
1.45B
48.62%
1.54B
6.54%
research and development expenses
10.08M
-
17.46M
73.15%
41.87M
139.78%
60.71M
45.01%
224.96M
270.57%
82.76M
63.21%
103.17M
24.66%
209.36M
102.93%
431.99M
106.33%
437.96M
1.38%
other expenses
-11.25M
-
-10.29M
8.53%
6.70M
165.08%
588K
91.22%
346K
41.16%
-944K
372.83%
3.39M
458.90%
1.79M
47.14%
-5.57M
410.83%
cost and expenses
116.87M
-
305.45M
161.36%
701.67M
129.72%
1.06B
51.39%
1.45B
36.37%
1.20B
17.33%
1.16B
2.93%
1.72B
47.56%
2.67B
55.83%
2.90B
8.47%
operating expenses
102.25M
-
226.69M
121.72%
482.17M
112.70%
669.01M
38.75%
902.33M
34.87%
775.25M
14.08%
800.28M
3.23%
1.18B
47.77%
1.88B
58.84%
1.98B
5.36%
interest expense
39.18M
-
23.83M
39.19%
69.90M
193.38%
86.61M
23.91%
126.52M
46.08%
121.69M
3.82%
87.09M
28.43%
59.62M
31.55%
81.06M
35.98%
83.71M
3.26%
ebitda
-33.54M
-
14.27M
142.53%
183.42M
1,185.65%
147.37M
19.66%
-108.37M
173.53%
286.08M
364.00%
373.79M
30.66%
767.98M
105.46%
909.04M
18.37%
1.11B
22.62%
operating income
-42.85M
-
-8.49M
80.19%
55.37M
752.13%
-147.17M
365.78%
-392.37M
166.61%
2.39M
100.61%
126.61M
5,193.10%
490.03M
287.03%
543.13M
10.84%
617.41M
13.68%
depreciation and amortization
9.31M
-
34.01M
265.30%
138.34M
306.78%
221.84M
60.35%
283.42M
27.76%
275.73M
2.71%
247.18M
10.36%
277.96M
12.45%
365.91M
31.64%
497.25M
35.89%
total other income expenses net
-68.09M
-
-237.37M
248.59%
-118.18M
50.21%
-60.31M
48.97%
5.62M
109.31%
-7.46M
232.81%
-146.84M
1,868.30%
-88.38M
39.81%
-80.30M
9.14%
-90.48M
12.67%
income before tax
-150.13M
-
-269.69M
79.64%
-132.71M
50.79%
-228.09M
71.86%
-513.27M
125.04%
-119.15M
76.79%
-20.22M
83.03%
401.64M
2,085.98%
462.83M
15.23%
526.94M
13.85%
income tax expense
-1.12M
-
-6.08M
442.73%
-172.24M
2,731.10%
-61.25M
64.44%
-102.75M
67.75%
-44.96M
56.24%
-593.24M
1,219.52%
11.85M
102.00%
-71.66M
704.81%
5.45M
107.61%
net income
-149.00M
-
-263.60M
76.91%
39.53M
115.00%
-166.83M
522.02%
-410.53M
146.07%
-74.19M
81.93%
573.02M
872.40%
389.80M
31.98%
534.49M
37.12%
521.48M
2.43%
weighted average shs out
63.66M
-
83.75M
31.56%
148.79M
77.65%
160.70M
8.01%
163.12M
1.51%
166.16M
1.86%
205.22M
23.51%
215.31M
4.91%
225.55M
4.76%
229.11M
1.58%
weighted average shs out dil
63.66M
-
83.75M
31.56%
155.92M
86.17%
160.70M
3.06%
163.12M
1.51%
166.16M
1.86%
205.22M
23.51%
215.31M
4.91%
235.68M
9.46%
235.24M
0.19%
eps
-2.34
-
-3.15
34.62%
0.27
108.57%
-1.04
485.19%
-2.52
142.31%
-0.45
82.14%
3.13
795.56%
1.91
38.98%
2.37
24.08%
2.28
3.80%
epsdiluted
-2.34
-
-3.15
34.62%
0.25
107.94%
-1.04
516%
-2.52
142.31%
-0.45
82.14%
2.90
744.44%
1.81
37.59%
2.27
25.41%
2.22
2.20%

All numbers in USD (except ratios and percentages)